Similarly, we found that tumor HHLA2 expression was related to suppressive antitumor immunity (specifically including reduced CD8+ TIL density and increased PD-1+ T cell levels) in the chordoma microenvironment. The gene discussed is HHLA2; the disease is neoplasm.